Volunteers gave blood, scans, and the secrets of their DNA to help science cure disease, yet the same data traveled across borders, landed on an e-commerce site, and revealed how easily controlled access can turn into copyable stock that outlives promises, policies, and platforms. The UK Biobank
At two in the morning, when hotlines queue and clinics are closed, people are confiding in AI chatbots that reply instantly, cost less than a co-pay, and feel safer than risking judgment from a stranger. Introduction AI mental health chatbots have moved from curiosity to commonplace, stepping into
Rising colorectal cancer deaths among adults under 50 have turned missed screenings into an avoidable market failure where operational friction, not medical knowledge, dictates outcomes and revenue. Market Context and Purpose Colorectal cancer screening has shifted from a routine age-based check to
A quiet revolution gathered force each time a clinician asked a deceptively simple question with life-and-death stakes: could the deadliest radiation be guided to the tumor’s heart and fade before it harms everything else nearby, leaving behind a crater of damage in cancer cells and a smaller b
Faisal Zain has spent years on factory floors and in clinical back rooms turning medical technology from schematics into approved devices. That end-to-end perspective—how ideas survive contact with regulators, providers, and patients—informs his work with Treehub’s cohort-based residencies in Los Al
The staggering reality of American healthcare is that for every dollar spent on treatment, a significant portion vanishes into a labyrinth of administrative friction and manual data entry. This overhead has remained stubbornly resistant to traditional digitization, yet the emergence of specialized
